Lymphoma, Large-Cell, Anaplastic - 3 Studies Found

Recruiting : Brentuximab Vedotin in Chinese Participants With Relapsed/Refractory CD30-Positive Hodgkin Lymphoma (HL) or Systemic Anaplastic Large Cell Lymphoma (sALCL)
:
  • Hodgkin Disease
  • Lymphoma, Large-Cell, Anaplastic

: 2016-10-18
: Drug: Brentuximab Vedotin Brentuximab vedotin IV infusion.
Recruiting : Study of the Biological Mechanisms Associated With the Immunogenicity in Anaplastic Large Cell Lymphoma ( ALCL ) ALK +
: ALCL
: 2016-09-07
: Other: Blood sample
Active, not recruiting : A Phase 1 Study of Brentuximab Vedotin Given Sequentially and Combined With Multi-Agent Chemotherapy for CD30-Positive Mature T-Cell and NK-Cell Neoplasms
:
  • Lymphoma, Large-Cell, Anaplastic
  • Lymphoma, NK-cell
  • : 2011-02-25
    :
    • Drug: brentuximab vedotin 1.2-